513 related articles for article (PubMed ID: 9032192)
1. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD.
Keatings VM; Jatakanon A; Worsdell YM; Barnes PJ
Am J Respir Crit Care Med; 1997 Feb; 155(2):542-8. PubMed ID: 9032192
[TBL] [Abstract][Full Text] [Related]
2. Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. The impact of smoking.
Pedersen B; Dahl R; Karlström R; Peterson CG; Venge P
Am J Respir Crit Care Med; 1996 May; 153(5):1519-29. PubMed ID: 8630596
[TBL] [Abstract][Full Text] [Related]
3. [The significance of inflammatory markers in sputum of asthmatic and chronic obstructive pulmonary diseases patients before and after glucocorticoid treatment].
Ma M; Fan W; Sun B; Li H
Zhonghua Nei Ke Za Zhi; 1999 Mar; 38(3):181-3. PubMed ID: 11798648
[TBL] [Abstract][Full Text] [Related]
4. Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects.
Keatings VM; Barnes PJ
Am J Respir Crit Care Med; 1997 Feb; 155(2):449-53. PubMed ID: 9032177
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects of budesonide on inflammatory status in COPD.
Boorsma M; Lutter R; van de Pol MA; Out TA; Jansen HM; Jonkers RE
COPD; 2008 Apr; 5(2):97-104. PubMed ID: 18415808
[TBL] [Abstract][Full Text] [Related]
6. Inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients.
Basyigit I; Yildiz F; Ozkara SK; Boyaci H; Ilgazli A
Mediators Inflamm; 2004 Aug; 13(4):285-91. PubMed ID: 15545060
[TBL] [Abstract][Full Text] [Related]
7. Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease.
Culpitt SV; Maziak W; Loukidis S; Nightingale JA; Matthews JL; Barnes PJ
Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1635-9. PubMed ID: 10556133
[TBL] [Abstract][Full Text] [Related]
8. [The relationship between sputum eosinophils and responses to treatment of inhaled glucocorticoids in patients with persistent asthma].
Jiang YW; Sun YC; Zhou QT; Gai XY; Cao WL; Yao WZ
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):447-51. PubMed ID: 17673020
[TBL] [Abstract][Full Text] [Related]
9. [Inhaled budesonide for chronic obstructive pulmonary disease].
Weiner P; Zamir D; Beckerman M
Harefuah; 1997 Jun; 132(11):756-9, 823. PubMed ID: 9223815
[TBL] [Abstract][Full Text] [Related]
10. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma.
Keatings VM; Collins PD; Scott DM; Barnes PJ
Am J Respir Crit Care Med; 1996 Feb; 153(2):530-4. PubMed ID: 8564092
[TBL] [Abstract][Full Text] [Related]
11. A comparison of nebulized budesonide with oral prednisolone in the treatment of exacerbations of obstructive pulmonary disease.
Morice AH; Morris D; Lawson-Matthew P
Clin Pharmacol Ther; 1996 Dec; 60(6):675-8. PubMed ID: 8988070
[TBL] [Abstract][Full Text] [Related]
12. A dose-dependent effect of the novel inhaled corticosteroid ciclesonide on airway responsiveness to adenosine-5'-monophosphate in asthmatic patients.
Taylor DA; Jensen MW; Kanabar V; Engelstätter R; Steinijans VW; Barnes PJ; O'Connor BJ
Am J Respir Crit Care Med; 1999 Jul; 160(1):237-43. PubMed ID: 10390406
[TBL] [Abstract][Full Text] [Related]
13. Changes in inflammatory markers following treatment of acute exacerbations of obstructive pulmonary disease.
Dahlén I; Janson C; Björnsson E; Stålenheim G; Peterson CG; Venge P
Respir Med; 2001 Nov; 95(11):891-7. PubMed ID: 11716203
[TBL] [Abstract][Full Text] [Related]
14. [Budesonide: efficacy and indications of low posology].
Malo JL
Rev Mal Respir; 1992; 9 Suppl 1():R73-7. PubMed ID: 1589634
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory effects of combined budesonide/formoterol in COPD exacerbations.
Bathoorn E; Liesker JJ; Postma DS; Boorsma M; Bondesson E; Koëter GH; Kauffman HF; van Oosterhout AJ; Kerstjens HA
COPD; 2008 Oct; 5(5):282-90. PubMed ID: 18972276
[TBL] [Abstract][Full Text] [Related]
16. Effects of inhaled nebulized steroids (budesonide) on acute and chronic lung function in heart-lung transplant patients.
Takao M; Higenbottam TW; Audley T; Otulana BA; Wallwork J
Transplant Proc; 1995 Feb; 27(1):1284-5. PubMed ID: 7878883
[No Abstract] [Full Text] [Related]
17. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.
de Jong JW; van der Mark TW; Koëter GH; Postma DS
Am J Respir Crit Care Med; 1996 Jan; 153(1):70-5. PubMed ID: 8542165
[TBL] [Abstract][Full Text] [Related]
18. Sequentially induced sputum in patients with asthma or chronic obstructive pulmonary disease.
Richter K; Holz O; Jörres RA; Mücke M; Magnussen H
Eur Respir J; 1999 Sep; 14(3):697-701. PubMed ID: 10543295
[TBL] [Abstract][Full Text] [Related]
19. Do patients with COPD benefit from treatment with inhaled corticosteroids?
van Schayck CP; van Grunsven PM; Dekhuijzen PN
Eur Respir J; 1996 Oct; 9(10):1969-72. PubMed ID: 8902451
[No Abstract] [Full Text] [Related]
20. Increase in airway neutrophils after oral but not inhaled corticosteroid therapy in mild asthma.
Nguyen LT; Lim S; Oates T; Chung KF
Respir Med; 2005 Feb; 99(2):200-7. PubMed ID: 15715187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
